The long-term neurodevelopmental outcomes of febrile seizures and underlying mechanisms

You Yi1, Chen Zhong1,2, Hu Wei-Wei1

  • 1Department of Pharmacology and Department of Pharmacy of the Second Affiliated Hospital, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, Zhejiang University School of Medicine, Hangzhou, China.

Insights

Febrile seizures (FSs) in children can lead to long-term neurodevelopmental issues like ADHD and epilepsy. Understanding FS mechanisms is crucial for preventing adverse outcomes and identifying biomarkers.

Area of Science:

  • Pediatric Neurology
  • Neurodevelopmental Disorders
  • Epileptology

Background:

  • Febrile seizures (FSs) affect up to 4% of young children, causing family anxiety and potential health risks.
  • FSs are linked to adverse neurodevelopmental outcomes, including ADHD, epilepsy, and cognitive decline.
  • The precise mechanisms underlying FS-induced developmental abnormalities and adult disease remain unclear.

Purpose of the Study:

  • To provide an overview of the association between FSs and neurodevelopmental outcomes.
  • To outline the underlying mechanisms of FSs' long-term effects.
  • To identify potential clinical biomarkers for FS-related disorders.

Main Methods:

  • Review of clinical and animal studies on FSs and neurodevelopment.
  • Analysis of histological and cellular molecular mechanisms.
  • Examination of the roles of inflammation and GABAergic systems.

Main Results:

  • The hippocampus is significantly altered post-FS, with potential involvement of the motor cortex and subcortical white matter.
  • FSs are associated with increased susceptibility to epilepsy, ADHD, hippocampal sclerosis, and cognitive decline.
  • Common mechanisms, including inflammation and GABA system dysregulation, may underlie multiple post-FS diseases.

Conclusions:

  • FSs have detrimental effects on neurodevelopment with potential long-term consequences into adulthood.
  • Further research into FS mechanisms and biomarkers is needed for effective clinical intervention.
  • Understanding the interplay of inflammation and GABA is key to addressing FS-related disorders.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
230
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
443
Long-term Potentiation01:25

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
2.8K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
351
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K